Sign In / Join

favorite Donate

close

person Sign In / Create Account

HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Crucial Lab Tests For Chronic Kidney Disease

Jul. 01, 2025

Crucial Lab Tests For Chronic Kidney Disease

New Way to Engineer CAR-T Cells Could Make it More Accessible

Jul. 01, 2025

New Way to Engineer CAR-T Cells Could Make it More Accessible

$Cilta-cel CAR T-cell Therapy: Unprecedented Long-Term Outcomes in Relapsed and Refractory Myeloma$

Jun. 23, 2025

Cilta-cel CAR T-cell Therapy: Unprecedented Long-Term Outcomes in Relapsed and Refractory Myeloma

The Impact of Income and Location in Myeloma Patients’ Outcomes

Jun. 23, 2025

The Impact of Income and Location in Myeloma Patients’ Outcomes

Accessing Specialized Care Centers Can Help Reduce Health Disparities for People with Multiple Myeloma

Jun. 19, 2025

Accessing Specialized Care Centers Can Help Reduce Health Disparities for People with Multiple Myeloma

Honoring Freedom, Advancing Health: Why Juneteenth Matters to the Black Blood Cancer Community

Jun. 19, 2025

Honoring Freedom, Advancing Health: Why Juneteenth Matters to the Black Blood Cancer Community

Dual Antibody Therapy for Extramedullary Myeloma

Jun. 17, 2025

Dual Antibody Therapy for Extramedullary Myeloma

$New Trispecific Antibody JNJ-5322 Shows Strong Results in Relapsed/Refractory Myeloma$

Jun. 16, 2025

New Trispecific Antibody JNJ-5322 Shows Strong Results in Relapsed/Refractory Myeloma

HealthTree Research: Helping Myeloma Patients Match Clinical Trials With AI

Jun. 13, 2025

HealthTree Research: Helping Myeloma Patients Match Clinical Trials With AI

New Guidelines Define High-Risk Myeloma with Genetics in Mind

Jun. 13, 2025

New Guidelines Define High-Risk Myeloma with Genetics in Mind

Optimizing Care for Frailty in Myeloma Patients

Jun. 12, 2025

Optimizing Care for Frailty in Myeloma Patients

Myeloma Pain Relief: What Patients Really Think About Opioids

Jun. 11, 2025

Myeloma Pain Relief: What Patients Really Think About Opioids

Recent Articles

Building Community is a Pillar of Self-Care image

Building Community is a Pillar of Self-Care

June 09, 2025

Discover how the HealthTree community supports people with blood cancer through education, coaching, and shared experiences.

Juliet Robertson’s Poetry on Living with AML image

Juliet Robertson’s Poetry on Living with AML

June 08, 2025

Juliet Robertson shares how poetry, walking, and reflection help her live meaningfully with AML in her new book Blood Lines.

Understanding Shared Decision-Making in Relapsed/Refractory Myeloma image

Understanding Shared Decision-Making in Relapsed/Refractory Myeloma

June 06, 2025

Learn how people with relapsed or refractory myeloma make treatment decisions and why shared decision-making leads to better satisfaction.

Treatment Advances

New Way to Engineer CAR-T Cells Could Make it More Accessible image

New Way to Engineer CAR-T Cells Could Make it More Accessible

Cilta-cel CAR T-cell Therapy: Unprecedented Long-Term Outcomes in Relapsed and Refractory Myeloma image

Cilta-cel CAR T-cell Therapy: Unprecedented Long-Term Outcomes in Relapsed and Refractory Myeloma

Dual Antibody Therapy for Extramedullary Myeloma image

Dual Antibody Therapy for Extramedullary Myeloma

A New Way to Administer Isatuximab (Sarclisa) That Reduces Side Effects image

A New Way to Administer Isatuximab (Sarclisa) That Reduces Side Effects

FDA Advisory Panel Supports Daratumumab for High-Risk Smoldering Multiple Myeloma image

FDA Advisory Panel Supports Daratumumab for High-Risk Smoldering Multiple Myeloma

New Treatment for Reducing the Risk of Graft Versus Host Disease After Allogeneic Stem Cell Transplant image

New Treatment for Reducing the Risk of Graft Versus Host Disease After Allogeneic Stem Cell Transplant

Load More

Core Education

Crucial Lab Tests For Chronic Kidney Disease image

Crucial Lab Tests For Chronic Kidney Disease

New Guidelines Define High-Risk Myeloma with Genetics in Mind image

New Guidelines Define High-Risk Myeloma with Genetics in Mind

What Are Natural Ways To Reduce Creatinine Levels? image

What Are Natural Ways To Reduce Creatinine Levels?

What Is APOL1 And How Does It Affect Kidney Disease? image

What Is APOL1 And How Does It Affect Kidney Disease?

How Are Steroids Used in Blood Cancer Treatment? image

How Are Steroids Used in Blood Cancer Treatment?

Zometa or Xgeva: Tailoring Bone Therapy in Multiple Myeloma image

Zometa or Xgeva: Tailoring Bone Therapy in Multiple Myeloma

Load More

Trending Articles

Cilta-cel CAR T-cell Therapy: Unprecedented Long-Term Outcomes in Relapsed and Refractory Myeloma

The Importance of Using Newer Myeloma Treatments Like CAR T-cell Therapy

New Guidelines Define High-Risk Myeloma with Genetics in Mind

Accessing Specialized Care Centers Can Help Reduce Health Disparities for People with Multiple Myeloma

What Are Natural Ways To Reduce Creatinine Levels?

Upcoming Events

Finding Strength in Community: How Support Networks Empower Myeloma Patients

Finding Strength in Community: How Support Networks Empower Myeloma Patients

Jul 09 / 16:00 EDT

Discover Cure Hub with the Annapolis, Maryland support group

Discover Cure Hub with the Annapolis, Maryland support group

Jul 10 / 10:00 EDT

Discover Cure Hub with the Western Wake , North Carolina IMF support group

Discover Cure Hub with the Western Wake , North Carolina IMF support group

Jul 12 / 10:00 EDT

Patient Stories

articles for Patient Stories

Juliet Robertson’s Poetry on Living with AML Stronger Together - Luis and Paola's Journey with Multiple Myeloma Redefining Patient Evidence: Giving Myeloma Patients a True Voice

HealthTree Research

articles for HealthTree Research

HealthTree Research: Helping Myeloma Patients Match Clinical Trials With AI Myeloma Pain Relief: What Patients Really Think About Opioids Understanding Shared Decision-Making in Relapsed/Refractory Myeloma

Conferences

articles for Conferences

The Impact of Income and Location in Myeloma Patients’ Outcomes Accessing Specialized Care Centers Can Help Reduce Health Disparities for People with Multiple Myeloma Comparing CRS and ICANS Among Bispecific Antibodies

Clinical Trials

articles for Clinical Trials

New Trispecific Antibody JNJ-5322 Shows Strong Results in Relapsed/Refractory Myeloma Moving Belantamab Mafodotin to Newly Diagnosed Myeloma? Targeting ROR1 in Blood Cancers

HealthTree Press

articles for HealthTree Press

The Importance of Using Newer Myeloma Treatments Like CAR T-cell Therapy Closing the Gaps in Multiple Myeloma Care for African Americans HealthTree Foundation CEO Jenny Ahlstrom Honored as 2025 Remarkable Women Honoree by ABC4 Utah

HealthTree Programs

articles for HealthTree Programs

Honoring Freedom, Advancing Health: Why Juneteenth Matters to the Black Blood Cancer Community Optimizing Care for Frailty in Myeloma Patients Building Community is a Pillar of Self-Care

Thanks to our sponsors:

All HealthTree resources available anywhere, anytime

Download our App

Download iOS App

Download Android App

iphone app mockup

Download our App

Download iOS App

Download Android App

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2025 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811